INTRODUCTION: Thyroid disease in men is rare and often associated with an increased risk of malignancy. Surgery remains an effective treatment option. METHODS: This was a retrospective study conducted over a ten-year period from 1 January 2011 to 30 June 2021 on 61 male patients with thyroid gland disease who underwent surgical treatment. RESULTS: The average age was 36 years with an average duration of 4.8 years. Eight patients reported a family history of goitre. Cervical lymphadenopathy was found in 1.6% of patients, exophthalmos in 17 patients (27.8%) and two patients presented signs of compression such as dysphagia and dysphonia. 65.6% of patients were euthyroid. Cervical ultrasound revealed thyroid nodules in 40%, hetero-multi-nodular goitre (HMNG) in 30% and diffuse hypervascular goitre in 30%. The EUTIRADS score was 43% for EUTIRADS 3, 28% for EUTIRADS 4 and 14% for EUTIRADS 1 and 15% for EUTIRADS 5, respectively. Fine needle aspiration was performed in 6 patients. Total thyroidectomy was performed in 85% of cases, with 2 mediastinal-recurrent lymph node dissection for papillary carcinoma and lobo-isthmectomy in 15%. Postoperative complications were minor in 87% of cases. CONCLUSION: Surgical thyroid disease in men is highly diverse and poses challenges for therapeutic management due to the risk of malignancy associated with the male sex.
References
[1]
Boumansour, N., Beldjilali, H., Agag, F., Ouhaj Tidjani, R. and Midoun, N. (2014) Profil épidémiologique des cancers thyroïdiens à l’Ouest algérien. Revue d’Épidémiologie et de Santé Publique, 62, S214. https://doi.org/10.1016/j.respe.2014.06.137
[2]
Ndiaye, I., Diouf, R., Diop, E.M. and Ndiaye, P.D. (1993) Thyroid Oncology in Practice—Based on 105 Cases. Annals of Otolaryngology and Cervicofacial Surgery, 110, 211-217.
[3]
Dieng, M., Ndour, O., Ka, O., Konate, I., Dia, A. and Toure, C.T. (2006) Surgical Treatment of Hyperthyroidism in Graves’ Disease and Nodular Goitre with Graves’ Disease. African Journal of Surgery, 9, 38-41.
[4]
Sissoko, F., Ongoiba, N., Traore, D., Kamate, B., Sidibe, A.T., Djeneba, D., et al. (2009) Thyroid Cancer in B Surgery at Point G Hospital. Mali Medical, 10, 34-36.
[5]
Toure, A., Diallo, A.T., Camara, L.M., Toure, F.B. and Camara, N.D. (2006) Thyroid Surgery: Experience of the General Surgery Department at Conakry University Hospital. Mali Medical, 21, 23-27.
[6]
Dillon, J.C., Sall, G., Ciornei, C., Faivre, D., Monnerie, F., Fouere, T., et al. (2002) Prevalence of Iodine Deficiency and Endemic Goitre in Eastern Senegal and Casamance. Médecined’Afrique Noire, 47, 366-373.
[7]
Daou, R. (1998) Hyperthyroidism and Thyroid Cancer. Surgery, 123, 604-608.
[8]
Agoda-Koussema, L.K., Adjenou, K., Amana, B., Goeh-Akue, K.E., et al. (2008) Ultrasound Aspects of Thyroid Gland Abnormalities in 134 Cases. Médecined’Afrique Noire, 55, 573-578.
[9]
Farah-Klibi, F. (2009) The Value of Extemporaneous Examination in Thyroid Nodule Surgery. Annales de pathologie, 29, 80-85.
[10]
Bouree, P., Ouedraogo, S. and Tapsoba, T.L. (2009) Contribution of Ultrasound to the Diagnosis of Thyroid Disease in Burkina Faso, Based on 54 Cases. Médecined’Afrique Noire, 56, 129-132.
[11]
Lassalle, S., Hofman, V., Butori, C., Long, E., et al. (2008) Role of the Cytopathologist in the Management of a Thyroid Nodule. Revue Francophone des Laboratoires, 398, 37-44.
[12]
Touati, M.M., Aljalil, A., Darouassi, Y., et al. (2015) Thyroid Carcinomas: Epidemiological, Clinical and Therapeutic Profiles, Based on 102 Cases. The Pan African Medical Journal, 21, 1-5.
[13]
Drouich, Y., El Aziz, S., Chadli, A., et al. (2018) Characteristics of Papillary Thyroid Carcinoma in Males. Annales d’Endocrinologie, 79, 339-355.
[14]
Alaoui, N.I. and Rais, N.B. (2011) Association between Hyperthyroidism and Differentiated Thyroid Cancer (Excluding Medullary Cancer). Seven Case Studies. MédecineNucléaire, 35, 570-577.
[15]
Do Cao, C. and Wémeau, J.L. (2008) Anaplastic Thyroid Cancers. The Annalesd’Endocrinologie, 69, 174-180.
[16]
Missaoui, B., Yeddes, I., Meddeb, I., et al. (2018) Particularity of Differentiated Thyroid Cancer Following Cervical Irradiation: A Case Study. Annales d’Endocrinologie, 79, Article 454.
[17]
Conessa, C.L., Sissokho, B. and Faye, M. (2000) Complications of Thyroid Surgery at the Dakar Main Hospital: A Report on 155 Procedures. Médecined’Afrique Noire, 47, 157-160.
[18]
Hounkpatin, S.H.R., et al. (2011) Histological Profile of Thyroid Tumefaction Operated in Benin. Rev. CAMES-Series A, 12, 106-108.
[19]
Darre, T., Amegbor, K., Amana, B., Pegbessou, F., Lawson, S., et al. (2014) Histological and Epidemiological Profile of Thyroid Body Tumours. Médecined’Afrique noire, 61, 249-251.
[20]
Murat, A. (1998) Early Therapeutic Management of Individuals Genetically Predisposed to Medullary Thyroid Cancer. Annales de chirurgie, 52, 455-460.
[21]
Ciappucini, R., Nascimento, C., Sanson, A.E. and Bardet, S. (2024) Nuclear Medicine and Thyroid Cancer in 2024: Iodine-131, PET and New Theranostic Approaches. Cancer Bulletin, 111, 64-72.
